| PH |
Report |
Adj. EPS (ex-amortization) |
BEAT |
pred ~$8.70 vs. cons $8.27 |
HIGH |
| PH |
Report |
Revenue |
BEAT |
pred ~$5.62B vs. cons $5.57B |
MEDIUM |
| PH |
Report |
Organic Growth % |
BEAT |
pred ~5.2% vs. cons 4.5% |
MEDIUM |
| PH |
Guide |
Adj. EPS Q4 FY26 (Q4 FY26) |
BETTER |
guide ~$8.70 vs. cons $8.27 |
HIGH |
| PH |
Guide |
Adj. EPS FY27 - first guide (FY27) |
BETTER |
guide ~$36.25 vs. cons $34.07 |
MEDIUM |
| PH |
Guide |
Organic Growth Q4 FY26 (Q4 FY26) |
BETTER |
guide ~5.2% vs. cons 4.5% |
MEDIUM |
| PH |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
MEDIUM |
| PH |
Return |
5-day cumulative residual |
+5.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH - FY27 guide drives estimate revisions upward; sell-side resets to new baseline over 5 days |
MEDIUM |